Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:223-227

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamura, K.
Right arrow Articles by Ishii, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamura, K.
Right arrow Articles by Ishii, M.

(Hypertension. 1998;32:223-227.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Effect of Genetic Deficiency of Angiotensinogen on the Renin-Angiotensin System

Kouichi Tamura; Satoshi Umemura; Yoichi Sumida; Nobuo Nyui; Shun-ichi Kobayashi; Tomoaki Ishigami; Minoru Kihara; Takeshi Sugaya; Akiyoshi Fukamizu; Hitoshi Miyazaki; Kazuo Murakami; ; Masao Ishii

From the Department of Internal Medicine II, Yokohama City University School of Medicine, Yokohama (K.T., S.U., Y.S., N.N., S.K., T.I., M.K., M.I.); Lead Generation Research Laboratories, Tanabe Seiyaku Co, Ltd, Osaka (T.S.); and the Institute of Applied Biochemistry (A.F., K.M.) and Gene Experiment Center (H.M.), University of Tsukuba, Ibaraki, Japan.

Correspondence to Kouichi Tamura, MD, Department of Internal Medicine II, Yokohama City University School of Medicine, 3–9, Fukuura, Kanazawa-ku, Yokohama 236, Japan. E-mail tamukou{at}yellow.med.yokohama-cu.ac.jp


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—This study examined expression of renin-angiotensin system (RAS) component mRNAs in angiotensinogen gene knockout (Atg-/-) mice. Wild-type (Atg+/+) and Atg-/- mice were fed a normal-salt (0.3% NaCl) or high-salt (4% NaCl) diet for 2 weeks. Angiotensinogen, renin, angiotensin-converting enzyme (ACE), angiotensin II type 1a receptor (AT1A), and angiotensin II type 2 receptor (AT2) mRNA levels were measured by Northern blot analysis. In Atg+/+ mice, activities of circulating RAS and renal angiotensinogen mRNA level were decreased by salt loading, whereas levels of renal and cardiac ACE; renal, brain, and cardiac AT1A; and brain and cardiac AT2 mRNA were increased by salt loading. Although activities of circulating RAS were not detected in Atg-/- mice, salt loading increased blood pressure in Atg-/- mice. In Atg-/- mice, renal renin mRNA level was decreased by salt loading; in contrast, salt loading increased renal AT1A and cardiac AT2 mRNA levels in Atg-/- mice, and these activated levels in Atg-/- mice were higher than those in Atg+/+ mice fed the high-salt diet. Thus, expression of each component of the RAS is regulated in a tissue-specific manner that is distinct from other components of systemic and local RAS and that appears to be mediated by a mechanism other than changes in the circulating or tissue levels of angiotensin peptides.


Key Words: renin-angiotensin system • angiotensinogen • angiotensin-converting enzyme • receptors, angiotensin • RNA, messenger • sodium, dietary


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The RAS plays a critical role in maintaining blood pressure and fluid electrolyte balance. The RAS historically has been viewed as a circulatory system. The various components of the RAS are produced by different organs and are delivered to their site of action by the bloodstream. However, accumulated evidence derived from biochemical and molecular studies of the physiological properties of angiotensin suggests that distinct local RAS with different regulatory mechanisms exist and function in the brain, heart, adrenal gland, kidney, vessel wall, and adipose tissue. Although it is controversial whether all components of the RAS are physiologically relevant and the exact pathophysiological role of the local RAS remains elusive, it is interesting to speculate that the local RAS may enhance the actions of Ang II in a specific physiological process of a given tissue system. In addition, previous studies showed that a variety of stimuli, including blood pressure, sodium intake, inflammation, and sympathetic nerve activity, modulate the expression of the tissue RAS genes in physiological and pathophysiological states.1 2 3 Furthermore, several studies using antagonists of Ang II receptor subtypes suggest that Ang II exerts various effects on the expression of major component genes of the RAS by positive or negative feedback mechanisms.4 5 6 7

Recently, we and others generated angiotensinogen-deficient mice by gene targeting.8 9 10 Homozygous mutant (Atg-/-) mice have no detectable plasma angiotensinogen or angiotensin peptides; they therefore lack a functional RAS and exhibit chronic hypotension. The aim of the present study was to examine whether dietary salt loading modulates the expression of major component genes of the RAS in Atg-/- mice without affecting angiotensin formation, as a first step to analyze a feedback mechanism by which angiotensin peptides exert influences on expression of the RAS gene.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animals
Atg-/- mice were generated by gene targeting as described previously.8 Atg-/- (n=12) and Atg+/+ (n=12) mice, aged 6 weeks, were used in this study. The mice were housed under a 12/12-hour day/night cycle at a temperature of 25°C and fed a normal-salt (0.3% NaCl) diet for 2 weeks. At 8 weeks of age, Atg-/- and Atg+/+ mice were divided into 2 groups, were placed on either a high-salt (4% NaCl) or normal-salt (0.3% NaCl) diet, and were kept in metabolic cages for determination of daily urine output and levels of urinary aldosterone and electrolytes. Tap water was provided ad libitum. At 10 weeks of age, SBP and BW were measured. SBP was measured by tail-cuff plethysmography. Mice were killed by decapitation. Brain, heart, and kidney were dissected out and immediately frozen in liquid nitrogen.

Biochemical Assays
The concentrations of electrolytes were measured with an automated analyzer for routine laboratory tests (Hitachi-736). Plasma Ang I concentration was measured with a radioimmunoassay kit (Renin Riabead Ang I kit, Dainabot Co Ltd).11 Plasma Ang II concentration was determined by a specific direct radioimmunoassay using an anti–Ang II antibody, as described previously, without an extraction procedure.12 Urinary concentrations of aldosterone were determined with a radioimmunoassay kit (SPAC-S aldosterone kit, Daiichi Radio-isotope Co).

For measurement of ACE activity in the kidney, the kidneys were homogenized in ACE homogenization buffer (50 mmol/L HEPES, pH 7.4, 150 mmol/L NaCl, 0.5% Triton X-100, 25 µmol/L ZnCl2, 1 mmol/L PMSF) and clarified by centrifugation for 15 minutes at 10 000g.13 Renal ACE activity was measured by a spectrophotometric assay kit using 3-(2-furylacryloyl)-L-phenylalanyl-glycyl-glycine (FAPGG) as substrate (Sigma Chemical Co).14 Total protein concentration in the kidney homogenates was calculated by the method of Lowry et al.15

RNA Isolation and Analysis
Total RNA from tissues was extracted with the guanidinium thiocyanate–cesium chloride centrifugation method.16 Each RNA sample (20 µg) was denatured with 1 mol/L glyoxal and 50% DMSO, electrophoresed on 1.2% agarose gels, and transferred onto nylon membranes (GeneScreen Plus, DuPont-New England Nuclear). Filters were prehybridized for 30 minutes at 60°C in a solution consisting of 1% SDS, 1 mol/L NaCl, and 10% dextran sulfate. Hybridization proceeded for 18 hours at 60°C in the same solution containing 300 µg/mL denatured salmon sperm DNA and 1x106 cpm/mL of the 32P-labeled probes for angiotensinogen,8 renin,17 ACE,18 AT1A,19 or AT2.20 Filters were washed twice with 2x SSC (1x SSC=150 mmol/L NaCl, 15 mmol/L sodium citrate) for 5 minutes at room temperature, twice with 2x SSC and 1% SDS for 30 minutes at 60°C, and twice with 0.1x SSC for 15 minutes at room temperature. Dried filters were exposed to an imaging plate of Fujix Bio-Imaging Analyzer BAS2000 (Fuji Photo Film). Expression of mRNA was quantified with the BAS2000 computer analyzer and normalized to the signal generated by probing for the constitutively expressed 18S rRNA gene.21

Statistical Analysis
For statistical analysis of differences among groups, the unpaired Student's t test or ANOVA followed by Scheffé's F test was used. All quantitative data are expressed as mean±SE. A value of P<0.05 was considered to indicate statistical significance.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
SBP and Circulating Angiotensin Peptides in Atg+/+ and Atg-/- Mice
As shown in Table 1Down, BW of Atg-/- mice at 10 weeks was lower than that of Atg+/+ mice. When fed the normal-salt diet, Atg-/- mice had significantly lower SBP and the ratio of HW to BW (HW/BW ratio) than Atg+/+ mice. In Atg-/- mice, SBP was significantly increased by the high-salt diet, whereas this diet had no effect on SBP in Atg+/+ mice and on HW/BW ratio in either Atg+/+ or Atg-/- mice. Plasma Ang I concentration, plasma Ang II concentration, and urinary aldosterone levels were below the detection limit of the assay systems in Atg-/- mice and were significantly decreased in Atg+/+ mice when they were fed the high-salt diet. Although Atg-/- mice showed an increased urine output and a decreased urine osmolality compared with Atg+/+ mice,22 urinary excretions of sodium and potassium were similar in these mice (Table 1Down).


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of Atg +/+ and Atg-/- Mice Fed a Normal- or High-Salt Diet

Effects of Salt Loading on mRNA Expression of RAS in Atg+/+ and Atg-/- Mice
Because the level of renal renin expression in Atg-/- mice is reported to be much higher than in Atg+/+ mice8 23 and the kidney plays a critical role in the maintenance of cardiovascular homeostasis, we examined expression of the RAS components in the kidney of Atg+/+ and Atg-/- mice and analyzed the effect of salt loading on expression of RAS as determined by Northern blot analysis (Figure 1Down). In the kidney, angiotensinogen mRNA is expressed in Atg+/+ mice but not in Atg-/- mice, and the high-salt diet decreased angiotensinogen mRNA levels in Atg+/+ mice. Atg-/- mice had higher levels of renin, ACE, and AT1A mRNA expression than Atg+/+ mice when fed the normal-salt diet; the high-salt diet significantly increased AT1A mRNA levels in both Atg-/- and Atg+/+ mice and ACE mRNA levels in Atg+/+ mice but decreased renin mRNA levels in Atg-/- mice. The ACE mRNA levels in Atg+/+ mice were comparable to those in Atg-/- mice fed the high-salt diet, and Atg-/- mice still had 5.3- and 2.0-fold higher levels of renin and AT1A mRNA expression than Atg+/+ mice, respectively, when fed the high-salt diet. The levels of ACE enzymatic activity showed the same trend with the ACE mRNA levels in the kidney of both Atg-/- and Atg+/+ mice (Table 2Down).



View larger version (55K):
[in this window]
[in a new window]
 
Figure 1. A, Representative Northern blot analysis showing the expression of angiotensinogen (Atg), renin, ACE, and AT1A mRNAs in the kidney of Atg+/+ and Atg-/- mice. Total RNA (20 µg) was isolated from the kidney of Atg+/+ and Atg-/- mice, electrophoresed, and hybridized with probes for Atg, renin, ACE, AT1A mRNAs, and 18S rRNA. B, Relative Atg, renin, ACE, and AT1A mRNA levels (n=6 in each group). The levels of mRNA expression were measured as radioactivities using a BAS2000 Imaging Analyzer, normalized relative to the radioactivity generated by probing for 18S rRNA expression, and expressed relative to those achieved with RNA from the kidney of Atg+/+ mice fed a normal-salt (0.3% NaCl) diet. Data are mean±SE from the 6 separate experiments.


View this table:
[in this window]
[in a new window]
 
Table 2. Renal ACE Activities of Atg +/+ and Atg-/- Mice Fed a Normal- or High-Salt Diet

In the brain, angiotensinogen mRNA is expressed in Atg+/+ mice but not in Atg-/- mice, and the high-salt diet had no significant effect on levels of angiotensinogen mRNA (Figure 2Down). Both AT1A and AT2 mRNA levels in Atg+/+ mice were comparable to those in Atg-/- mice fed the normal-salt diet. In Atg+/+ mice, the high-salt diet significantly increased AT1A and AT2 mRNA levels, whereas in Atg-/- mice the high-salt diet had no effect on such levels. The levels of cardiac ACE, AT1A, and AT2 mRNA expression were similar in Atg+/+ and Atg-/- mice fed the normal-salt diet (Figure 3Down).24 The high-salt diet significantly increased ACE, AT1A, and AT2 mRNA levels in Atg+/+ mice. In Atg-/- mice, the high-salt diet did not affect cardiac ACE or AT1A mRNA levels, but it significantly increased cardiac AT2 mRNA expression to 1.4-fold higher than that in Atg+/+ mice fed the high-salt diet.



View larger version (60K):
[in this window]
[in a new window]
 
Figure 2. A, Representative Northern blot analysis showing the expression of angiotensinogen (Atg), AT1A, and AT2 mRNAs in the brain of Atg+/+ and Atg-/- mice. Total RNA (20 µg) was isolated from the brain of Atg+/+ and Atg-/- mice, electrophoresed, and hybridized with probes for Atg, AT1A, AT2 mRNAs, and 18S rRNA. B, Relative Atg, AT1A, and AT2 mRNA levels (n=6 in each group). The levels of mRNA expression were measured as radioactivities using a BAS2000 Imaging Analyzer, normalized relative to the radioactivity generated by probing for 18S rRNA expression, and expressed relative to those achieved with RNA from the brain of Atg+/+ mice fed a normal-salt (0.3% NaCl) diet. Data are mean±SE from the 6 separate experiments.



View larger version (69K):
[in this window]
[in a new window]
 
Figure 3. A, Representative Northern blot analysis showing the expression of ACE, AT1A, and AT2 mRNAs in the heart of Atg+/+ and Atg-/- mice. Total RNA (20 µg) was isolated from the heart of Atg+/+ and Atg-/- mice, electrophoresed, and hybridized with probes for ACE, AT1A, AT2 mRNAs, and 18S rRNA. B, Relative ACE, AT1A, and AT2 mRNA levels (n=6 in each group). The levels of mRNA expression were measured as radioactivities using a BAS2000 Imaging Analyzer, normalized relative to the radioactivity generated by probing for 18S rRNA expression, and expressed relative to those achieved with RNA from the heart of Atg+/+ mice fed a normal-salt (0.3% NaCl) diet. Data are mean±SE from the 6 separate experiments.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Previous studies of regulation of the RAS components in genetically or experimentally hypertensive animals showed widespread abnormalities of RAS gene expression that were modulated in some tissues by the development of hypertension.1 2 3 However, little is known about regulation of the RAS genes in hypotensive animals. Because Atg-/- mice do not produce angiotensin peptides at all and thus are chronically hypotensive, Atg-/- mice may be a genetically suitable hypotension model for analysis of the regulation of RAS gene expression in vivo. In the present study, we showed that salt loading significantly increased SBP in Atg-/- mice and that expression of the RAS genes was regulated in a tissue-specific manner by salt loading in Atg-/- mice.

Consistent with the results of previous studies,8 23 we showed an increase in the levels of renin mRNA in the kidney of Atg-/- mice compared with Atg+/+ mice. The mRNA levels of ACE and AT1A were also increased in the kidney of Atg-/- mice. Upregulation of ACE and AT1A mRNA levels in Atg-/- mice was observed in the kidney but not in either the brain or heart when these mice were fed the normal-salt diet. These results suggest that expression of the renal ACE and AT1A genes is specifically activated in Atg-/- mice. Previous studies revealed that the kidney in Atg-/- mice was undergoing numerous pathological changes, including marked vascular hypertrophy, interstitial inflammation, atrophic changes in the tubules and papilla, and increased expression of growth factors and neuronal nitric oxide synthase genes,9 10 23 as well as increased urine output and decreased urine osmolality compared with Atg+/+ mice.22 In contrast to these remarkable abnormalities in the kidney, no appreciable abnormality was found in the brain or heart of Atg-/- mice.9 Thus, these pathological changes may be involved in increases in the mRNA levels of ACE and AT1A in the kidney in Atg-/- mice fed the normal-salt diet. In particular, Atg-/- mice have reduced renal medullas; thus, their renal RNA is enriched in RNA from the renal cortex where ACE is produced. This could explain the elevations of ACE mRNA levels observed in Atg-/- mice. Another possibility is that the higher mRNA levels of ACE and AT1A in the kidney of Atg-/- mice than of Atg+/+ mice may be due to complete disruption of the negative feedback of Ang II on ACE- and AT1A-expressing cells in the kidney of Atg-/- mice.4 5 Further study is needed to clarify the mechanisms responsible for these increases in the kidney of Atg-/- mice.

Tissue ACE in the heart may play a role in the pathogenesis of cardiac hypertrophy and remodeling.25 However, little is known regarding the regulation of the cardiac ACE gene by altered sodium intake. In this study, salt loading increased the cardiac ACE mRNA levels in Atg+/+ mice but not in Atg-/- mice. Because a previous study showed a significant increase in cardiac ACE mRNA in response to a high-sodium diet in both Wistar-Kyoto and stroke-prone spontaneously hypertensive rats,26 the findings in the present study suggest that angiotensin peptides are necessary for a salt-mediated increase in the cardiac ACE mRNA levels.

Similar to the regulation of cardiac ACE gene, salt loading increased the brain and cardiac AT1A mRNA levels in Atg+/+ mice but not in Atg-/- mice. Previous studies showed that high sodium intake increased expression of the AT1A mRNA in the brain and kidney.7 27 28 Dietary sodium loading is known to suppress the circulating RAS and to decrease circulating levels of Ang II. Because Ang II downregulates expression of the AT1A gene,5 the decrease in circulating Ang II levels by salt loading may upregulate AT1A gene expression. In the present study, there was no significant difference in AT1A mRNA expression in the brain and heart in Atg+/+ and Atg-/- mice when fed the normal salt diet, and salt loading increased the AT1A mRNA levels in Atg+/+ mice but not in Atg-/- mice. Thus, complete lack of angiotensin peptides may make the AT1A gene unable to respond to salt loading in the brain and heart.

In contrast to the AT1A gene, much less is known about the regulation of the AT2 gene. Abundant expression of AT2 has been found in the mesenchymal tissues of a developing rat fetus, indicating an important role of AT2 in growth, development, and apoptosis.29 30 Previous studies reported an increase in AT2 expression in the hypertrophic myocardium of experimental hypertensive rats and showed that the process of cardiac remodeling after myocardial infarction induced not only AT1A but also AT2 expression.31 32 In the present study, salt loading increased the brain AT2 mRNA levels in Atg+/+ mice but not in Atg-/- mice. On the other hand, the treatment upregulated the cardiac AT2 mRNA levels in both Atg+/+ and Atg-/- mice, and the activated levels of cardiac AT2 mRNA were higher in Atg-/- mice than in Atg+/+ mice. Therefore, these results suggest that the complete lack of angiotensin peptide activates the salt-mediated expression of cardiac AT2 mRNA but inhibits the salt-mediated expression of brain AT2 mRNA.

In conclusion, the findings obtained in the present study suggest that dietary salt loading exerts a systemic influence on the RAS component genes differently in Atg+/+ and Atg-/- mice. Future research must elucidate the systemic and cellular mechanisms by which salt intake modulates the expression of RAS genes and the possible roles of angiotensin peptides in these mechanisms.


*    Selected Abbreviations and Acronyms
 
ACE = angiotensin-converting enzyme
Ang = angiotensin
AT1A = angiotensin II type 1A receptor
AT2 = angiotensin II type 2 receptor
BW = body weight
HW = wet tissue heart weight
RAS = renin-angiotensin system
SBP = systolic blood pressure


*    Acknowledgments
 
This work was supported in part by grants from the Ministry of Education, Science, and Culture of Japan; the Ichiro Kanehara Foundation; the Uehara Memorial Foundation; the Yokohama Foundation for Advancement of Medical Science; and the Naito Memorial Foundation.

Received March 10, 1998; first decision March 16, 1998; accepted March 20, 1998.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Griendling KK, Murphy TJ, Alexander RW. Molecular biology of the renin-angiotensin system. Circulation. 1993;87:1816–1828.[Free Full Text]

2. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine: a paradigm shift? Circulation. 1994;89:493–498.[Free Full Text]

3. Tamura K, Umemura S, Fukamizu A, Ishii M, Murakami K. Recent advances in the study of renin and angiotensinogen genes: from molecules to the whole body. Hypertens Res. 1995;18:7–18.[Medline] [Order article via Infotrieve]

4. Kohara K, Brosnihan KB, Ferrario CM, Milsted A. Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system. Am J Physiol. 1992;262:E651–E657.[Abstract/Free Full Text]

5. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 1995;48:601–609.[Abstract]

6. Schricker K, Holmer S, Kramer BK, Riegger GA, Kurtz A. The role of angiotensin II in the feedback control of renin gene expression. Pflugers Arch. 1997;434:166–172.[Medline] [Order article via Infotrieve]

7. Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Llorens-Cortes C, Corvol P, Schambelan M. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension. 1996;28:403–408.[Abstract/Free Full Text]

8. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K. Angiotensinogen-deficient mice with hypotension. J Biol Chem. 1994;269:31334–31337.[Abstract/Free Full Text]

9. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, Inagami T, Hogan BLM, Ichikawa I. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest. 1995;96:2947–2954.

10. Kim H-S, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995;92:2735–2739.[Abstract/Free Full Text]

11. Tokita Y, Franco-Saenz R, Reimann EM, Mulrow PJ. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen. Hypertension. 1994;23:422–427.[Abstract/Free Full Text]

12. Shimamoto K, Ishida H, Nakahashi Y, Nishitani T, Hosoda S, Yokoyama T, Tanaka S, Iimura O. A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases. Jpn Circ J. 1984;48:1228–1235.[Medline] [Order article via Infotrieve]

13. Esther CR Jr, Howard TE, Marino EM, Goddard JM, Capecchi MR, Bernstein KE. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest. 1996;74:953–965.[Medline] [Order article via Infotrieve]

14. Johansen KB, Marstein S, Aas P. Automated method for the determination of angiotensin-converting enzyme in serum. Scand J Clin Lab Invest. 1987;47:411–414.[Medline] [Order article via Infotrieve]

15. Lowry OH, Rosebrough NJ, Lewis Farr A, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–275.[Free Full Text]

16. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in nuclease. Biochemistry. 1979;18:5294–5299.[Medline] [Order article via Infotrieve]

17. Tamura K, Umemura S, Yamaguchi S, Iwamoto T, Kobayashi S, Fukamizu A, Murakami K, Ishii M. Mechanism of cAMP regulation of renin gene transcription by proximal promoter. J Clin Invest. 1994;94:1959–1967.

18. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A. 1988;85:9386–9390.[Abstract/Free Full Text]

19. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A, Uchida H, Sugiura M, Fukuta K, Fukamizu A, Murakami K. Angiotensin type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem. 1995;270:18719–18722.[Abstract/Free Full Text]

20. Kobayashi S, Ohnishi J, Nibu Y, Nishimatsu S, Umemura S, Ishii M, Murakami K, Miyazaki H. Cloning of the rat angiotensin type II receptor gene and identification of its functional promoter region. Biochim Biophys Acta. 1995;1262:155–158.[Medline] [Order article via Infotrieve]

21. Raynal F, Michot B, Bachellerie J-P. Complete nucleotide sequence of mouse 18S rRNA gene: comparison with other available homologs. FEBS Lett. 1984;167:263–268.[Medline] [Order article via Infotrieve]

22. Umemura S, Kihara M, Sumida Y, Yabana M, Ishigami T, Tamura K, Nyui N, Hibi K, Murakami K, Fukamizu A, Ishii M. Endocrinological abnormalities in angiotensinogen-gene knockout mice: studies of hormonal responses to dietary salt loading. J Hypertens. 1998;16:285–289.[Medline] [Order article via Infotrieve]

23. Kihara M, Umemura S, Kadota T, Yabana M, Tamura K, Nyui N, Ogawa N, Murakami K, Fukamizu A, Ishii M. The neuronal isoform of constitutive nitric oxide synthase is up-regulated in the macula densa of angiotensinogen gene knockout mice. Lab Invest. 1997;76:285–294.[Medline] [Order article via Infotrieve]

24. Sumida Y, Umemura S, Tamura K, Kihara M, Kobayashi S, Ishigami T, Yabana M, Nyui N, Ochiai H, Fukamizu A, Miyazaki N, Murakami K, Ishii M. Increased cardiac angiotensin II receptors in angiotensinogen-deficient mice. Hypertension. 1998;31:45–49.[Abstract/Free Full Text]

25. Johnston CI. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension. 1994;23:258–268.[Free Full Text]

26. Kreutz R, Fernandez-Alfonso MS, Liu Y, Ganten D, Paul M. Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats. J Mol Med. 1995;73:243–248.[Medline] [Order article via Infotrieve]

27. Sandberg K, Ji H, Catt KJ. Regulation of angiotensin II receptors in rat brain during dietary sodium changes. Hypertension. 1994;23:I-137–I-141.

28. Ruan X, Wagner C, Chatziantoniou C, Kurtz A, Arendshorst WJ. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. J Clin Invest. 1997;99:1072–1081.[Medline] [Order article via Infotrieve]

29. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991;88:921–933.

30. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem. 1997;272:19022–19026.[Abstract/Free Full Text]

31. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993;73:439–447.[Abstract/Free Full Text]

32. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995;95:46–54.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. J. Murphey, W. K. Eccles, G. H. Williams, and N. J. Brown
Loss of Sodium Modulation of Plasma Kinins in Human Hypertension
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1046 - 1052.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. H. Carlson, S. Oparil, Y.-F. Chen, and J. M. Wyss
Blood Pressure and NaCl-Sensitive Hypertension Are Influenced by Angiotensin-Converting Enzyme Gene Expression in Transgenic Mice
Hypertension, February 1, 2002; 39(2): 214 - 218.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. E. Gerlofs-Nijland, K. J. M. Assmann, H. B. P. M. Dijkman, J. W.C. Dieker, J. P. H. F. van Son, S. Mentzel, J. P. van Kats, A. H. J. Danser, O. Smithies, P. J. T. A. Groenen, et al.
Albuminuria in Mice after Injection of Antibodies against Aminopeptidase A: Role of Angiotensin II
J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2711 - 2720.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. C. Cholewa and D. L. Mattson
Role of the renin-angiotensin system during alterations of sodium intake in conscious mice
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R987 - R993.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tamura, N. Nyui, N. Tamura, T. Fujita, M. Kihara, Y. Toya, I. Takasaki, N. Takagi, M. Ishii, K.-i. Oda, et al.
Mechanism of Angiotensin II-mediated Regulation of Fibronectin Gene in Rat Vascular Smooth Muscle Cells
J. Biol. Chem., October 9, 1998; 273(41): 26487 - 26496.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamura, K.
Right arrow Articles by Ishii, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamura, K.
Right arrow Articles by Ishii, M.